Home » Topics » BioWorld Science

BioWorld Science
RSS

RAPT Therapeutics patents USP7 inhibitors

April 21, 2020

BCH-070, a novel antiparasitic candidate against multidrug-resistant malaria

April 21, 2020

First COVID-19 patient treated under emergency use IND with Stemedica's itMSCs

April 21, 2020

Promising topline data for Xeris' novel intramuscular injection formulation of diazepam

April 21, 2020

Alexion to initiate global phase III study of Ultomiris in severe COVID-19

April 21, 2020

Long noncoding RNA has sex-specific role in depression

April 21, 2020

FDA clears IND to initiate phase I/II study of PRGN-2009

April 21, 2020

Phase III CheckMate-9ER study of Opdivo and Cabometyx in RCC meets primary endpoint

April 21, 2020

Pivotal CheckMate-743 trial of Opdivo plus Yervoy in MPM meets primary endpoint

April 21, 2020

Anixa and OntoChem collaborate to develop novel antiviral therapies against COVID-19

April 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...